Anavex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. 

CEO
Christopher U. Missling
CEOChristopher U. Missling
Employees
40
Employees40
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2004
Founded2004
Employees
40
Employees40

AVXL Key Statistics

Market cap
314.49M
Market cap314.49M
Price-Earnings ratio
-7.19
Price-Earnings ratio-7.19
Dividend yield
—
Dividend yield—
Average volume
1.20M
Average volume1.20M
High today
$3.98
High today$3.98
Low today
$3.81
Low today$3.81
Open price
$3.89
Open price$3.89
Volume
872.27K
Volume872.27K
52 Week high
$10.45
52 Week high$10.45
52 Week low
$3.25
52 Week low$3.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.